Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells

Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemical research in toxicology 2014-03, Vol.27 (3), p.408-420
Hauptverfasser: Waldmann, Tanja, Rempel, Eugen, Balmer, Nina V, König, André, Kolde, Raivo, Gaspar, John Antonydas, Henry, Margit, Hescheler, Jürgen, Sachinidis, Agapios, Rahnenführer, Jörg, Hengstler, Jan G, Leist, Marcel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 420
container_issue 3
container_start_page 408
container_title Chemical research in toxicology
container_volume 27
creator Waldmann, Tanja
Rempel, Eugen
Balmer, Nina V
König, André
Kolde, Raivo
Gaspar, John Antonydas
Henry, Margit
Hescheler, Jürgen
Sachinidis, Agapios
Rahnenführer, Jörg
Hengstler, Jan G
Leist, Marcel
description Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.
doi_str_mv 10.1021/tx400402j
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3958134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1524411226</sourcerecordid><originalsourceid>FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</originalsourceid><addsrcrecordid>eNptkV9P2zAUxS00tHbdHvYFkF8mbQ8B_0uaviChBhgSEkgDiTfLca47V4kd7KSCbz_TQjUknmzr_nzuvecg9J2SY0oYPRmeBCGCsPUBmtKckSwnlHxCU1IueMZY-TBBX2JcE0ITPv-MJkzwkovFfIr6CqJdOXwbrNO2byFib_DSOw1uCGqw3mUV9OCa9MZ3Qbmog-0H3wGuYGO3RMTW4SqMq-z8qfcRGlxZYyCkLy-AW-E_A3R4CW0bv6JDo9oI317PGbq_OL9b_s6uby6vlmfXmRKFGDKleWHonNcc6kLQkqUrU3lpFBjFddGUHCinDWhKhWDQaC1qYgzLkxFG13yGTne6_Vh3qbxdp5V9sJ0Kz9IrK99XnP0rV34j-SIvKRdJ4OerQPCPI8RBdjbqtIJy4Mcok9FCUMpYkdBfO1QHH2MAs29DiXxJSO4TSuzR_3PtybdIEvBjBygd5dqPwSWbPhD6B0XYm5s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1524411226</pqid></control><display><type>article</type><title>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</title><source>ACS Publications</source><source>MEDLINE</source><creator>Waldmann, Tanja ; Rempel, Eugen ; Balmer, Nina V ; König, André ; Kolde, Raivo ; Gaspar, John Antonydas ; Henry, Margit ; Hescheler, Jürgen ; Sachinidis, Agapios ; Rahnenführer, Jörg ; Hengstler, Jan G ; Leist, Marcel</creator><creatorcontrib>Waldmann, Tanja ; Rempel, Eugen ; Balmer, Nina V ; König, André ; Kolde, Raivo ; Gaspar, John Antonydas ; Henry, Margit ; Hescheler, Jürgen ; Sachinidis, Agapios ; Rahnenführer, Jörg ; Hengstler, Jan G ; Leist, Marcel</creatorcontrib><description>Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.</description><identifier>ISSN: 0893-228X</identifier><identifier>EISSN: 1520-5010</identifier><identifier>DOI: 10.1021/tx400402j</identifier><identifier>PMID: 24383497</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Binding Sites ; Cell Differentiation - drug effects ; Cells, Cultured ; Cluster Analysis ; Down-Regulation - drug effects ; Embryonic Stem Cells - cytology ; Embryonic Stem Cells - drug effects ; Embryonic Stem Cells - metabolism ; Humans ; Neural Plate - cytology ; Neural Plate - metabolism ; Principal Component Analysis ; Transcription Factors - genetics ; Transcription Factors - metabolism ; Transcriptome - drug effects ; Up-Regulation - drug effects ; Valproic Acid - chemistry ; Valproic Acid - toxicity</subject><ispartof>Chemical research in toxicology, 2014-03, Vol.27 (3), p.408-420</ispartof><rights>Copyright © 2014 American Chemical Society</rights><rights>Copyright © 2014 American Chemical Society 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</citedby><cites>FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/tx400402j$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/tx400402j$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24383497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Waldmann, Tanja</creatorcontrib><creatorcontrib>Rempel, Eugen</creatorcontrib><creatorcontrib>Balmer, Nina V</creatorcontrib><creatorcontrib>König, André</creatorcontrib><creatorcontrib>Kolde, Raivo</creatorcontrib><creatorcontrib>Gaspar, John Antonydas</creatorcontrib><creatorcontrib>Henry, Margit</creatorcontrib><creatorcontrib>Hescheler, Jürgen</creatorcontrib><creatorcontrib>Sachinidis, Agapios</creatorcontrib><creatorcontrib>Rahnenführer, Jörg</creatorcontrib><creatorcontrib>Hengstler, Jan G</creatorcontrib><creatorcontrib>Leist, Marcel</creatorcontrib><title>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</title><title>Chemical research in toxicology</title><addtitle>Chem. Res. Toxicol</addtitle><description>Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.</description><subject>Binding Sites</subject><subject>Cell Differentiation - drug effects</subject><subject>Cells, Cultured</subject><subject>Cluster Analysis</subject><subject>Down-Regulation - drug effects</subject><subject>Embryonic Stem Cells - cytology</subject><subject>Embryonic Stem Cells - drug effects</subject><subject>Embryonic Stem Cells - metabolism</subject><subject>Humans</subject><subject>Neural Plate - cytology</subject><subject>Neural Plate - metabolism</subject><subject>Principal Component Analysis</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><subject>Transcriptome - drug effects</subject><subject>Up-Regulation - drug effects</subject><subject>Valproic Acid - chemistry</subject><subject>Valproic Acid - toxicity</subject><issn>0893-228X</issn><issn>1520-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>EIF</sourceid><recordid>eNptkV9P2zAUxS00tHbdHvYFkF8mbQ8B_0uaviChBhgSEkgDiTfLca47V4kd7KSCbz_TQjUknmzr_nzuvecg9J2SY0oYPRmeBCGCsPUBmtKckSwnlHxCU1IueMZY-TBBX2JcE0ITPv-MJkzwkovFfIr6CqJdOXwbrNO2byFib_DSOw1uCGqw3mUV9OCa9MZ3Qbmog-0H3wGuYGO3RMTW4SqMq-z8qfcRGlxZYyCkLy-AW-E_A3R4CW0bv6JDo9oI317PGbq_OL9b_s6uby6vlmfXmRKFGDKleWHonNcc6kLQkqUrU3lpFBjFddGUHCinDWhKhWDQaC1qYgzLkxFG13yGTne6_Vh3qbxdp5V9sJ0Kz9IrK99XnP0rV34j-SIvKRdJ4OerQPCPI8RBdjbqtIJy4Mcok9FCUMpYkdBfO1QHH2MAs29DiXxJSO4TSuzR_3PtybdIEvBjBygd5dqPwSWbPhD6B0XYm5s</recordid><startdate>20140317</startdate><enddate>20140317</enddate><creator>Waldmann, Tanja</creator><creator>Rempel, Eugen</creator><creator>Balmer, Nina V</creator><creator>König, André</creator><creator>Kolde, Raivo</creator><creator>Gaspar, John Antonydas</creator><creator>Henry, Margit</creator><creator>Hescheler, Jürgen</creator><creator>Sachinidis, Agapios</creator><creator>Rahnenführer, Jörg</creator><creator>Hengstler, Jan G</creator><creator>Leist, Marcel</creator><general>American Chemical Society</general><scope>N~.</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>20140317</creationdate><title>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</title><author>Waldmann, Tanja ; Rempel, Eugen ; Balmer, Nina V ; König, André ; Kolde, Raivo ; Gaspar, John Antonydas ; Henry, Margit ; Hescheler, Jürgen ; Sachinidis, Agapios ; Rahnenführer, Jörg ; Hengstler, Jan G ; Leist, Marcel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a464t-ac36f173b3eb6418273b2a58faefa3c6d83e131dec11442edcc4b0ff25040fcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Binding Sites</topic><topic>Cell Differentiation - drug effects</topic><topic>Cells, Cultured</topic><topic>Cluster Analysis</topic><topic>Down-Regulation - drug effects</topic><topic>Embryonic Stem Cells - cytology</topic><topic>Embryonic Stem Cells - drug effects</topic><topic>Embryonic Stem Cells - metabolism</topic><topic>Humans</topic><topic>Neural Plate - cytology</topic><topic>Neural Plate - metabolism</topic><topic>Principal Component Analysis</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><topic>Transcriptome - drug effects</topic><topic>Up-Regulation - drug effects</topic><topic>Valproic Acid - chemistry</topic><topic>Valproic Acid - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Waldmann, Tanja</creatorcontrib><creatorcontrib>Rempel, Eugen</creatorcontrib><creatorcontrib>Balmer, Nina V</creatorcontrib><creatorcontrib>König, André</creatorcontrib><creatorcontrib>Kolde, Raivo</creatorcontrib><creatorcontrib>Gaspar, John Antonydas</creatorcontrib><creatorcontrib>Henry, Margit</creatorcontrib><creatorcontrib>Hescheler, Jürgen</creatorcontrib><creatorcontrib>Sachinidis, Agapios</creatorcontrib><creatorcontrib>Rahnenführer, Jörg</creatorcontrib><creatorcontrib>Hengstler, Jan G</creatorcontrib><creatorcontrib>Leist, Marcel</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chemical research in toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Waldmann, Tanja</au><au>Rempel, Eugen</au><au>Balmer, Nina V</au><au>König, André</au><au>Kolde, Raivo</au><au>Gaspar, John Antonydas</au><au>Henry, Margit</au><au>Hescheler, Jürgen</au><au>Sachinidis, Agapios</au><au>Rahnenführer, Jörg</au><au>Hengstler, Jan G</au><au>Leist, Marcel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells</atitle><jtitle>Chemical research in toxicology</jtitle><addtitle>Chem. Res. Toxicol</addtitle><date>2014-03-17</date><risdate>2014</risdate><volume>27</volume><issue>3</issue><spage>408</spage><epage>420</epage><pages>408-420</pages><issn>0893-228X</issn><eissn>1520-5010</eissn><abstract>Information on design principles governing transcriptome changes upon transition from safe to hazardous drug concentrations or from tolerated to cytotoxic drug levels are important for the application of toxicogenomics data in developmental toxicology. Here, we tested the effect of eight concentrations of valproic acid (VPA; 25–1000 μM) in an assay that recapitulates the development of human embryonic stem cells to neuroectoderm. Cells were exposed to the drug during the entire differentiation process, and the number of differentially regulated genes increased continuously over the concentration range from zero to about 3000. We identified overrepresented transcription factor binding sites (TFBS) as well as superordinate cell biological processes, and we developed a gene ontology (GO) activation profiler, as well as a two-dimensional teratogenicity index. Analysis of the transcriptome data set by the above biostatistical and systems biology approaches yielded the following insights: (i) tolerated (≤25 μM), deregulated/teratogenic (150–550 μM), and cytotoxic (≥800 μM) concentrations could be differentiated. (ii) Biological signatures related to the mode of action of VPA, such as protein acetylation, developmental changes, and cell migration, emerged from the teratogenic concentrations range. (iii) Cytotoxicity was not accompanied by signatures of newly emerging canonical cell death/stress indicators, but by catabolism and decreased expression of cell cycle associated genes. (iv) Most, but not all of the GO groups and TFBS seen at the highest concentrations were already overrepresented at 350–450 μM. (v) The teratogenicity index reflected this behavior, and thus differed strongly from cytotoxicity. Our findings suggest the use of the highest noncytotoxic drug concentration for gene array toxicogenomics studies, as higher concentrations possibly yield wrong information on the mode of action, and lower drug levels result in decreased gene expression changes and thus a reduced power of the study.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>24383497</pmid><doi>10.1021/tx400402j</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-228X
ispartof Chemical research in toxicology, 2014-03, Vol.27 (3), p.408-420
issn 0893-228X
1520-5010
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3958134
source ACS Publications; MEDLINE
subjects Binding Sites
Cell Differentiation - drug effects
Cells, Cultured
Cluster Analysis
Down-Regulation - drug effects
Embryonic Stem Cells - cytology
Embryonic Stem Cells - drug effects
Embryonic Stem Cells - metabolism
Humans
Neural Plate - cytology
Neural Plate - metabolism
Principal Component Analysis
Transcription Factors - genetics
Transcription Factors - metabolism
Transcriptome - drug effects
Up-Regulation - drug effects
Valproic Acid - chemistry
Valproic Acid - toxicity
title Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A49%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20Principles%20of%20Concentration-Dependent%20Transcriptome%20Deviations%20in%20Drug-Exposed%20Differentiating%20Stem%20Cells&rft.jtitle=Chemical%20research%20in%20toxicology&rft.au=Waldmann,%20Tanja&rft.date=2014-03-17&rft.volume=27&rft.issue=3&rft.spage=408&rft.epage=420&rft.pages=408-420&rft.issn=0893-228X&rft.eissn=1520-5010&rft_id=info:doi/10.1021/tx400402j&rft_dat=%3Cproquest_pubme%3E1524411226%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1524411226&rft_id=info:pmid/24383497&rfr_iscdi=true